Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Adding celecoxib with or without Zoledronic acid for hormone-naive prostate cancer: Long-term survival results from an adaptive, multiarm, multistage, platform, randomized controlled trial

Mason, Malcolm D., Clarke, Noel W., James, Nicholas D., Dearnaley, David P., Spears, Melissa R., Ritchie, Alastair W. S., Attard, Gerhardt, Cross, William, Jones, Rob J., Parker, Christopher C., Russell, J. Martin, Thalmann, George N., Schiavone, Francesca, Cassoly, Estelle, Matheson, David, Millman, Robin, Rentsch, Cyrill A., Barber, Jim, Gilson, Clare, Ibrahim, Azman, Logue, John, Lydon, Anna, Nikapota, Ashok D., O'Sullivan, Joe M., Porfiri, Emilio, Protheroe, Andrew, Srihari, Narayanan Nair, Tsang, David, Wagstaff, John, Wallace, Jan, Walmsley, Catherine, Parmar, Mahesh K. B. and Sydes, Matthew R. 2017. Adding celecoxib with or without Zoledronic acid for hormone-naive prostate cancer: Long-term survival results from an adaptive, multiarm, multistage, platform, randomized controlled trial. Journal of Clinical Oncology 35 (14) , pp. 1530-1541. 10.1200/JCO.2016.69.0677

[img]
Preview
PDF - Published Version
Download (323kB) | Preview
Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: American Society of Clinical Oncology
ISSN: 0732-183X
Date of First Compliant Deposit: 2 October 2017
Last Modified: 01 Nov 2017 02:32
URI: http://orca-mwe.cf.ac.uk/id/eprint/102657

Citation Data

Cited 16 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics